European Society for Medical Oncology (ESMO) Breast Cancer 2019

European Society for Medical Oncology (ESMO) Breast Cancer is organized by European Society for Medical Oncology (ESMO) and will be held from May 02 - 04, 2019 at Maritim Hotel Berlin, Berlin, Germany.

The target audience for this medical event is designed for breast cancer researchers and clinicians who have a specific interest in innovation (including translational research, new agents, molecular and functional diagnostics, biomarkers and cutting-edge research applications in the clinical setting) and care. This Conference has been approved for a maximum of 17 ESMO-MORA category 1 points.

Conference Description:
The 2019 programme features sessions on innovative treatments, DNA damage, early clinical opportunities, immunotherapy and breast cancer response, metabolism, regulation of breast cancer diversity, and resistance to targeted therapy. These topics span basic, clinical, epidemiologic, prevention, and translational research areas that have implications for treatment now and in the future.

Cancer patients and their needs are at the heart of what we do – we are committed to advancing research and integrating it into the clinic to ensure better care for our patients. 

In recent years, we have seen remarkable progress in treatment options and improved outcomes for breast cancer patients. 

We are committed to delivering a comprehensive overview of all the practice-changing new data and making sure it has a clear roadmap to the clinic to improve care for patients.

Brought to you by ESMO, your trusted provider of specialised education in oncology, the congress is designed by the world’s foremost experts in breast cancer, authors with an outstanding publication track record.

We welcome the very best clinical and translational research and we look forward to showcasing outstanding original data. 

ESMO Breast Cancer will offer immediate global visibility to practice-changing developments.

Conference Objectives:
• To advance knowledge
• To integrate translational research into cancer care
• To further improve precision medicine
• To disseminate education and
• To improve the practice of breast cancer specialists worldwide

Additional details will be posted as soon as they are available.